- Review the burden of the disease - screening recommendations for osteoporosis from endocrine and primary care perspectives
- Expanding treatment beyond the bisphosphonates -provide an update on newer osteoanabolic pharmacotherapies for osteoporosis; Bone loss and vertebral fractures after denosumab discontinuation - are there strategies to prevent this?
- Provide an Update on Clinical Bone Trials at University of Chicago - PATH Forward, ATOM, WearABLe trials
03/09/2020 - 5:00pm to 6:00pm CDT
Add to calendar:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Tamara Vokes, M.D. and Meltem Zeytinoglu, M.D., MBA